COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,797 Articles (22,527 medRxiv, 8,270 bioRxiv)

Most recent first Previous |  Page 2713: Articles 27121-27130  | Next

Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.
Case, J. B., Rothlauf, P. W., Chen, R. E., Liu, Z., Zhao, H., Kim, A. S., Bloyet, L.-M., Zeng, Q., Tahan, S., Droit, L., Ilagan, M. X. G., Tartell, M. A., Amarasinghe, G. K., Henderson, J. P., Miersch, S., Ustav, M., Sidhu, S., Virgin, H. W., Wang, D., Ding, S., Corti, D., Theel, E. S., Fremont, D. H., Diamond, M. S., Whelan, S. P. J.
10.1101/2020.05.18.102038 — Posted: 2020-05-18
SARS-CoV2 infection in farmed mink, Netherlands, April 2020
Oreshkova, N., Molenaar, R.-J., Vreman, S., Harders, F., Oude Munnink, B. B., Hakze-vd Honing, R. W., Gerhards, N., Tolsma, P., Bouwstra, R., Sikkema, R., Tacken, M., de Rooij, M. M. T., Weesendorp, E., Engelsma, M., Bruschke, C., Smit, L. A. M., Koopmans, M., van der Poel, W. H. M., Stegeman, J.
10.1101/2020.05.18.101493 — Posted: 2020-05-18 Discussion: Offsite
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection
Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R., Mathew, D., Baxter, A. E., Vella, L., Kuthuru, O., Apostolidis, S., Bershaw, L., Dougherty, J., Greenplate, A. R., Pattekar, A., Kim, J., Han, N., Gouma, S., Weirick, M. E., Arevalo, C. P., Bolton, M. J., Goodwin, E. C., Anderson, E. M., Hensley, S. E., Jones, T. K., Mangalmurti, N. S., Luning Prak, E. T., Meyer, N. J., Kim, J., Betts, M. R.
10.1101/2020.05.18.101717 — Posted: 2020-05-18 Discussion: Onsite | Offsite
Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
Henderson, R., Edwards, R. J., Mansouri, K., Janowska, K., Stalls, V., Gobeil, S., Kopp, M., Hsu, A. L., Borgnia, M. J., Parks, R., Haynes, B. F., Acharya, P.
10.1101/2020.05.18.102087 — Posted: 2020-05-18 Discussion: Offsite
Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection
Minervina, A. A., Komech, E. A., Titov, A., Bensouda Koraichi, M., Rosati, E., Mamedov, I. Z., Franke, A., Efimov, G. A., Chudakov, D. M., Mora, T., Walczak, A. M., Lebedev, Y. B., Pogorelyy, M. V.
10.1101/2020.05.18.100545 — Posted: 2020-05-18 Discussion: Onsite | Offsite
Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
Pique-Regi, R., Romero, R., Tarca, A. L., Luca, F., Xu, Y., Leng, Y., Hsu, C.-D., Gomez-Lopez, N.
10.1101/2020.05.18.101485 — Posted: 2020-05-18
Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19
Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Linty, F., Visser, R., Brinkhaus, M., Sustic, T., deTaeye, S. W., Bentlage, A. E. H., Nouta, J., Natunen, S., Koeleman, C. A. M., Sainio, S., Kootstra, N. A., Brouwer, P. J. M., Sanders, R. W., van Gils, M. J., de Bruin, S., Vlaar, A. P. J., Amsterdam UMC COVID-19 biobank study group, , Zaaijer, H. L., Wuhrer, M., van der Schoot, C. E., Vidarsson, G.
10.1101/2020.05.18.099507 — Posted: 2020-05-18
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Thoms, M., Buschauer, R., Ameismeier, M., Koepke, L., Denk, T., Hirschenberger, M., Kratzat, H., Hayn, M., Mackens-Kiani, T., Cheng, J., Stuerzel, C. M., Froehlich, T., Berninghausen, O., Becker, T., Kirchhoff, F., Sparrer, K. M. J., Beckmann, R.
10.1101/2020.05.18.102467 — Posted: 2020-05-18 Discussion: Onsite | Offsite
Robot dance: a city-wise automatic control of Covid-19 mitigation levels
Silva, P. J. S., Pereira, T., Nonato, L. G.
10.1101/2020.05.11.20098541 — Posted: 2020-05-18 Discussion: Onsite
Estimating the true (population) infection rate for COVID-19: A Backcasting Approach with Monte Carlo Methods
Phipps, S. J., Grafton, R. Q., Kompas, T.
10.1101/2020.05.12.20098889 — Posted: 2020-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).